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journal homepage: www.j-bgm.comABSTRACTTransfection anti-beta-catenin intrabody to
suppress cancer cell by blocking Wnt pathwayDer-An Tsao a, Shu-Mei Yang a, Chen-Rou Yang a,
Yu-Hsiang Kang a, Ya-Cin Lai a, Pei-Yu Chen a, Yi-Han Wang a,
Shih-Yu Huang a, Wei-Chang Tseng a, Han-Chung Wu ba Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung, Taiwan
b Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, TaiwanBackground: Wnt signaling results in beta-catenin accumulation and transcriptional activation of specific target genes
during development. Deregulation of beta-catenin signaling is an important event in the genesis of a number of malig-
nancies, such as colon cancer, melanoma, hepatocellular carcinoma, ovarian cancer and prostate cancer. Conventional
chemotherapeutic drugs used for the treatment of cancer patients in advanced stages have yielded only limited benefit. To
improve the clinical outcome of cancer, agents aimed at novel molecular targets are required. Expression of intrabodies has
become a broadly applicable technology for generation of phenotypic knockouts in vivo.
Materials and Methods: In order to study the biological consequences of knocking down beta-catenin, we developed a
novel intrabody-based strategy by phage display system.
Results: We successfully isolated novel anti-beta-catenin scFv clones and confirmed strong binding affinity by ELISA
method. Otherwise, obvious suppression tumor cell proliferation after transfection of novel anti-beta-catenin scFv clones
was identified by Annexin-V apoptosis assay. Disruption of this signaling pathway holds promise for the development of new
anti-cancer drugs.
Discussion: Our aim was to develop novel therapeutic strategies to interfere with tumor growth by blocking the Wnt/beta-
catenin pathway.http://dx.doi.org/10.1016/j.bgm.2014.09.004
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